TrialThe New England journal of medicine2026

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Christopher C Butler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.